Oncolytic virotherapy reverses chemoresistance in osteosarcoma by suppressing MDR1 expression.
Sugiu K, Tazawa H, Hasei J, Yamakawa Y, Omori T, Komatsubara T, Mochizuki Y, Kondo H, Osaki S, Fujiwara T, Yoshida A, Kunisada T, Ueda K, Urata Y, Kagawa S, Ozaki T, Fujiwara T.
Sugiu K, et al. Among authors: fujiwara t.
Cancer Chemother Pharmacol. 2021 Sep;88(3):513-524. doi: 10.1007/s00280-021-04310-5. Epub 2021 Jun 10.
Cancer Chemother Pharmacol. 2021.
PMID: 34114067
Free article.